- Home
- CMPX vs RGC Comparison
CMPX vs RGC Comparison
Compare CMPX & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- RGC
- Stock Information
- Founded
- CMPX 2014
- RGC 2014
- Country
- CMPX United States
- RGC Hong Kong
- Employees
- CMPX N/A
- RGC N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- RGC Medicinal Chemicals and Botanical Products
- Sector
- CMPX Health Care
- RGC Health Care
- Exchange
- CMPX Nasdaq
- RGC Nasdaq
- Market Cap
- CMPX 291.8M
- RGC 38.6B
- IPO Year
- CMPX N/A
- RGC 2021
- Fundamental
- Price
- CMPX $2.65
- RGC $14.66
- Analyst Decision
- CMPX Strong Buy
- RGC
- Analyst Count
- CMPX 9
- RGC 0
- Target Price
- CMPX $12.67
- RGC N/A
- AVG Volume (30 Days)
- CMPX 797.6K
- RGC 2.8M
- Earning Date
- CMPX 08-11-2025
- RGC 06-30-2025
- Dividend Yield
- CMPX N/A
- RGC N/A
- EPS Growth
- CMPX N/A
- RGC N/A
- EPS
- CMPX N/A
- RGC N/A
- Revenue
- CMPX $850,000.00
- RGC N/A
- Revenue This Year
- CMPX N/A
- RGC N/A
- Revenue Next Year
- CMPX N/A
- RGC N/A
- P/E Ratio
- CMPX N/A
- RGC N/A
- Revenue Growth
- CMPX N/A
- RGC N/A
- 52 Week Low
- CMPX $0.87
- RGC $0.08
- 52 Week High
- CMPX $4.08
- RGC $83.60
- Technical
- Relative Strength Index (RSI)
- CMPX 64.52
- RGC 45.32
- Support Level
- CMPX $2.62
- RGC $9.39
- Resistance Level
- CMPX $2.87
- RGC $30.00
- Average True Range (ATR)
- CMPX 0.16
- RGC 6.44
- MACD
- CMPX 0.00
- RGC -1.70
- Stochastic Oscillator
- CMPX 81.03
- RGC 20.68
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.